Evidence map›Paper›PMID 41828373›Full record

ReviewInternational journal of molecular sciences2026

A Developmental Perspective on the Intestinal Microbiota in Crohn's Disease.

Marcello Imbrizi, Daniela Oliveira Magro, Andrey Santos, Heloisa Balan Assalin, Dioze Guadagnini, Mario José Abdalla Saad, Claudio Saddy Rodrigues Coy

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marcello ImbriziDivision of Gastroenterology, Department of Internal Medicine, University of Campinas (UNICAMP), 420 Carlos Chagas St, Campinas 13083-878, SP, Brazil.ORCID 0000-0001-5397-0084
Daniela Oliveira MagroDepartment of Surgery, University of Campinas (UNICAMP), Campinas 13083-878, SP, Brazil.ORCID 0000-0002-8180-6254
Andrey SantosDepartment of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-878, SP, Brazil.
Heloisa Balan AssalinDepartment of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-878, SP, Brazil.ORCID 0000-0003-1269-9624
Dioze GuadagniniDepartment of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-878, SP, Brazil.
Mario José Abdalla SaadDepartment of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-878, SP, Brazil.
Claudio Saddy Rodrigues CoyDepartment of Surgery, University of Campinas (UNICAMP), Campinas 13083-878, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crohn's disease (CD) is a chronic inflammatory disorder arising from the convergence of genetic susceptibility, immune dysregulation, environmental exposures, and perturbations of the gut microbiome. This review advances a developmental and compartment-aware framework for interpreting dysbiosis in CD, integrating spatial heterogeneity, transmural pathology, and mesenteric interactions. By synthesizing evidence on microbial composition, functional metabolism, and host-immune crosstalk, we describe a dysbiotic profile shaped by disease location, inflammatory activity, and therapeutic exposure, while also considering the emerging roles of non-bacterial members. We propose that microbiome alterations in CD reflect inflammation-driven ecosystem instability rather than a static taxonomic imbalance. Moving beyond descriptive compositional profiling toward a dynamic ecological model that incorporates disease trajectory and anatomical compartmentalization is essential to refine disease stratification and guide future microbiome-informed precision therapies.

Indexed as

Crohn DiseaseDysbiosisGastrointestinal MicrobiomeAnimalsHumansbarrier functionCrohn’s diseasedysbiosisgut microbiomehost–microbiomeimmune regulationinflammatory bowel diseasemetabolitesmulti-omics

Identifiers

PMID41828373
PMCPMC12984778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.